relapsed multiple myeloma

Related by string. Relapsed Multiple Myeloma * Relapsed . Relapsing . relapser : relapsing remitting multiple sclerosis . relapsed ovarian cancer . relapsing remitting / multiples . Multiples . MULTIPLE : multiple gunshot wounds . multiple stab wounds . multiple skull fractures / Myeloma . myelomas : relapsed refractory multiple myeloma . diagnosed multiple myeloma . untreated multiple myeloma * *

Related by context. All words. (Click for frequent words.) 76 relapsed refractory multiple myeloma 73 relapsed MM 73 Omacetaxine 72 refractory chronic lymphocytic 72 metaglidasen 72 alvespimycin 72 sorafenib tablets 71 phase IIb clinical 71 cell lymphoma CTCL 71 refractory metastatic colorectal cancer 71 Annamycin 71 dasatinib Sprycel ® 71 VELCADE melphalan 71 recurrent glioblastoma multiforme 71 leukemia AML 71 relapsed leukemia 71 advanced carcinoid 71 FOLOTYN ® 71 bendamustine 71 refractory multiple myeloma 71 oral ridaforolimus 71 standard chemotherapy regimen 71 Amrubicin 71 metastatic CRC 71 Aflibercept 71 erlotinib Tarceva ® 71 metastatic renal cell carcinoma 71 galiximab 71 evaluating tivozanib 70 elotuzumab 70 bortezomib Velcade R 70 OncoVEX GM CSF 70 refractory gout 70 herpetic keratitis 70 YONDELIS 70 bevacizumab Avastin ® 70 lenalidomide Revlimid R 70 forodesine 70 ACTEMRA TM 70 lumiliximab 70 CTAP# Capsules 70 Cloretazine 70 ganetespib 70 sunitinib malate 70 metastatic hormone refractory 70 HER2 positive metastatic breast 70 sorafenib Nexavar ® 70 Ceflatonin R 70 cancer neuroendocrine tumor 70 Neulasta R 70 mapatumumab 70 AEG# 70 phase IIb trial 70 docetaxel chemotherapy 70 AEGR 70 Nexavar ® 69 docetaxel Taxotere R 69 leukemia CLL 69 mitoxantrone plus 69 TREANDA 69 plus prednisone 69 prostate cancer HRPC 69 Myelodysplastic Syndrome MDS 69 azacitidine 69 LEUKINE 69 pertuzumab 69 docetaxel Taxotere ® 69 Troxatyl 69 Alocrest 69 systemic anaplastic large 69 Pemetrexed 69 dacarbazine 69 PSMA ADC 69 MAGE A3 ASCI 69 vinca alkaloid 69 cyclophosphamide chemotherapy 69 PNP inhibitor 69 cutaneous T 69 Xanafide 69 rALLy clinical trial 69 antibody MAb 69 multiple myeloma MM 69 imatinib Gleevec ® 69 refractory NSCLC 69 oxypurinol 69 CIMZIA ™ 69 HGS ETR1 69 pegylated interferon alpha 69 CD# antibody [001] 68 adalimumab Humira 68 plus dexamethasone 68 glufosfamide 68 IV Busulfex 68 paclitaxel Taxol ® 68 platinum refractory 68 ELACYT 68 Neulasta ® 68 AQ4N 68 metastatic GIST 68 Meets Primary Endpoint 68 dasatinib Sprycel 68 refractory Hodgkin lymphoma 68 lymphoma CTCL 68 adult chronic ITP 68 Irinotecan 68 Doxil ® 68 entinostat 68 aflibercept VEGF Trap 68 elacytarabine 68 oral prodrug 68 virus HCV protease inhibitor 68 Personalized Immunotherapy 68 liposomal formulation 68 recurrent glioblastoma 68 FOLOTYN 68 Golimumab 68 relapsing remitting MS RRMS 68 castrate resistant prostate cancer 68 SPRYCEL ® 68 metastatic castration resistant 68 candesartan cilexetil 68 HuMax EGFr 68 CYT# potent vascular disrupting 68 Fludara 68 CIMZIA TM 68 Fibrillex TM 68 FOLFOX6 68 sorafenib Nexavar 68 R sorafenib tablets 68 Cleviprex TM clevidipine 68 nucleoside analog 68 Pegasys ® 68 MGd 68 terlipressin 68 pan HDAC inhibitor 68 Aloxi injection 68 HGS# 68 Cutaneous T 68 Dacogen injection 68 Panzem R NCD 68 pegylated liposomal doxorubicin 68 radiation sensitizer 68 trabectedin 68 hematological malignancy 68 Phase IIIb clinical 68 MYDICAR ® 68 refractory cutaneous T 68 Virulizin ® 68 Ceflatonin 68 PHX# 68 carboplatin chemotherapy 68 cediranib 68 recurrent NSCLC 68 Genasense ® 68 phase IIa clinical 68 HuMax CD4 68 DOXIL 68 capecitabine Xeloda R 68 axitinib 68 PDX pralatrexate 68 thalidomide Thalomid 68 JAK inhibitor 68 EOquin TM 68 mRCC 68 pegfilgrastim 68 Gemzar ® 68 diabetic neuropathic pain 68 Tarceva erlotinib 68 Voreloxin 68 methylnaltrexone bromide 68 alfa 2a 68 receptor tyrosine kinase inhibitor 68 induced macular edema 68 relapsing multiple sclerosis 67 Clolar ® 67 Vicinium TM 67 gemcitabine cisplatin 67 farletuzumab 67 cetuximab Erbitux R 67 acetonide FA 67 PKC# 67 EGFR expressing mCRC 67 Cloretazine R VNP#M 67 IRX 2 67 Daclizumab 67 investigational monoclonal antibody 67 atrial fibrillation budiodarone ATI 67 Pegasys peginterferon alfa 2a 67 BAY #-# 67 cutaneous T cell 67 refractory CLL 67 Pegylated Interferon 67 PROCRIT ® 67 vinorelbine 67 RhuDex ® 67 Azedra 67 KRN# 67 indolent NHL 67 Vaprisol 67 HRPC 67 ZOLINZA 67 romidepsin 67 omega interferon 67 SUTENT 67 Phase Ib II 67 Tamibarotene 67 heavily pretreated 67 palifosfamide 67 immunotherapeutic agent 67 Hodgkin lymphoma NHL 67 Fludara ® 67 GRN# 67 TTF Therapy 67 Diabetic Macular Edema 67 ritonavir boosted 67 Peg IFN 67 catheter occlusion 67 Oral NKTR 67 thetreatment 67 trastuzumab Herceptin R 67 sunitinib 67 dacetuzumab 67 refractory AML 67 Copegus ribavirin 67 evaluating T DM1 67 huC# DM4 67 CIMZIA TM certolizumab pegol 67 Nexavar sorafenib 67 RLY# 67 Onco TCS 67 resistant ovarian cancer 67 systemic ALCL 67 constipation OIC 67 oral rivaroxaban 67 docetaxel Taxotere 67 CCX# B 67 severe hypercholesterolemia 67 Taxotere R 67 Neupogen ® 67 OHR/AVR# 67 Aplidin 67 BARACLUDE R 67 rituximab refractory 67 MabThera Rituxan 67 Azilect ® 67 advanced metastatic renal 67 tumors GIST 67 angiotensin receptor blocker ARB 67 relapsing remitting multiple sclerosis 67 hyperphenylalaninemia HPA due 67 oxaliplatin Eloxatin 67 PREZISTA r 67 INTEGRILIN 67 gastrointestinal stromal tumors GIST 67 Dapagliflozin 67 Clevudine 67 DAVANAT 67 Traficet EN 67 Phase Ib study 67 BRIM2 67 Rituxan rituximab 67 Trastuzumab 67 LymphoStat B belimumab 67 CBLC# 67 BARACLUDE ® 67 ThermoDox R 67 tolvaptan 67 rilonacept 67 PXD# 67 Elotuzumab 67 delivers fluocinolone acetonide FA 67 PEG Interferon lambda 67 Evoltra ® 67 Ixempra 67 Velcade bortezomib 67 DPP4 inhibitor 67 Myocet 67 deforolimus 67 INCB# [001] 67 targeted radiotherapeutic 67 metastatic renal cell 67 Dacogen decitabine 67 tanespimycin 67 Phase #b/#a clinical 67 Proxinium TM 67 Epratuzumab 67 PRT# 67 ORENCIA R 67 Hsp# Inhibitor 67 plus DOXIL 67 cetuximab Erbitux ® 67 hormone refractory metastatic prostate 67 BCG refractory carcinoma 67 IMiDs R 67 interferon beta therapy 67 IMA# 67 perifosine 66 Seliciclib 66 vidofludimus 66 L Annamycin 66 gemcitabine carboplatin 66 assessing T DM1 66 Ophena TM 66 OvaRex ® MAb 66 xanthine oxidase inhibitor 66 regorafenib 66 nab paclitaxel 66 TORISEL 66 ZACTIMA 66 IMiDs 66 Herceptin trastuzumab 66 IMiDs ® 66 pegylated interferon alpha 2a 66 Taxotere ® 66 carboplatin paclitaxel 66 Diabetic Macular Edema DME 66 Xeloda ® 66 ixabepilone 66 cilengitide 66 anthracycline taxane 66 reslizumab 66 Acute Myeloid Leukemia AML 66 FIRMAGON 66 diarrhea predominant irritable 66 chlorambucil 66 ® bortezomib 66 humanized anti 66 idiopathic pulmonary fibrosis IPF 66 ribavirin RBV 66 obatoclax 66 pegylated interferons 66 APTIVUS r 66 opioid induced bowel dysfunction 66 MyVax R 66 opioid induced constipation OIC 66 pancreatic NET 66 PD LID 66 FOLFOX4 66 Mipomersen 66 Jevtana 66 toenail onychomycosis 66 de novo kidney transplant 66 Folfox 66 refractory PTCL 66 ThermoDox ® 66 virus HCV infection 66 Revlimid lenalidomide 66 relapsed CLL 66 OZURDEX ® 66 eosinophilic asthma 66 Natalizumab 66 subcutaneous formulation 66 GW# [003] 66 eltrombopag 66 Genentech Rituxan 66 AVASTIN 66 octreotide implant 66 romiplostim 66 recurrent metastatic ovarian cancer 66 esophageal candidiasis 66 primary hypercholesterolemia 66 vinorelbine tartrate 66 Vidaza ® 66 LymphoStat B TM 66 Quinamed 66 INTEGRILIN R 66 IMC A# 66 intravesical infusion therapy 66 Phase 2b clinical 66 Sapacitabine 66 Cloretazine ® 66 autoantibody positive 66 Navelbine ® 66 sapropterin dihydrochloride Tablets 66 TELINTRA 66 Bortezomib 66 leading oral taxane 66 plus prednisone prednisolone 66 Bezielle 66 gemcitabine chemotherapy 66 Tarceva TM 66 DU #b 66 CA4P 66 plus gemcitabine 66 sunitinib Sutent ® 66 Ozarelix 66 Phase Ib 66 midstage clinical 66 sorafenib Nexavar R 66 acyclovir Lauriad R 66 ofatumumab HuMax CD# 66 cisplatin gemcitabine 66 Gemcitabine 66 histone deacetylase HDAC inhibitor 66 lomitapide 66 PEGINTRON TM 66 oral antiviral 66 oxymorphone ER 66 fallopian tube carcinoma 66 Pertuzumab 66 tesetaxel 66 oral proteasome inhibitor 66 IAP inhibitor 66 Gleevec resistant 66 Cimzia ® 66 custirsen 66 visilizumab 66 Relapsed Refractory 66 relapsed SCLC 66 erlotinib Tarceva R 66 metastatic malignant melanoma 66 Imprime PGG 66 lintuzumab SGN 66 ARCALYST 66 Rituximab 66 brand ciclesonide HFA 66 AVONEX ® 66 amrubicin 66 gemcitabine Gemzar 66 hA# 66 IMiDs ® compound 66 intravenously administered 66 adecatumumab 66 unique alkylating agent 66 BENLYSTA ® 66 Raptiva ® 66 Ventavis 66 oral deforolimus 66 CoFactor 66 Zorbtive TM 66 hepatitis C HCV 66 MT# MEDI 66 Increlex ® 66 chronic HCV infection 66 riociguat 66 pomalidomide 66 Brentuximab Vedotin SGN 66 idarubicin 66 VELCADE 66 SAR# [004] 66 telaprevir dosed 66 Tiuxetan 66 Vidaza 66 dacarbazine DTIC 66 zalutumumab 66 ceftazidime 66 HGS ETR2 66 atacicept 66 ALN HPN 66 capecitabine Xeloda 66 ORENCIA ® 66 carfilzomib 66 VNP#M 66 Naive Patients 66 cyclophosphamide methotrexate 66 Chemophase 66 INTEGRILIN ® 66 PEG interferon 66 Cimzia TM 66 ILUVIEN ® 66 unresectable liver cancer 66 SUPPRELIN R LA 65 enzastaurin 65 huN# DM1 65 MYCAMINE 65 EOquin 65 castration resistant prostate cancer 65 Blinatumomab 65 docetaxel prednisone 65 thymalfasin 65 PEGylated Fab fragment 65 Insegia 65 atypical Hemolytic Uremic Syndrome 65 superficial bladder cancer 65 NXL# 65 Pazopanib 65 talactoferrin 65 Combo Stent 65 subcutaneously administered 65 PegIFN RBV 65 Hormone Refractory Prostate Cancer 65 invasive candidiasis 65 Glufosfamide 65 TRO# 65 Allovectin 7 65 paclitaxel Taxol R 65 SNT MC# 65 novel VDA molecule 65 non nucleoside inhibitor 65 FUSILEV enhances 65 chronic lymphocytic leukemia CLL 65 Panzem R 65 Phase Ib clinical 65 chronic angina 65 CD3 monoclonal antibody 65 BrachySil TM 65 Mitoxantrone 65 cangrelor 65 biliary tract cancer 65 HQK 65 hepatorenal syndrome 65 Archexin 65 non splenectomized 65 biologic DMARD 65 demonstrated antitumor activity 65 follicular NHL 65 myelodysplastic myeloproliferative diseases 65 Romidepsin 65 THALOMID 65 Pradefovir 65 2 methoxyestradiol 65 decitabine 65 CR# vcMMAE 65 Gleevec imatinib 65 OMP #R# 65 5 FU leucovorin 65 PEGylated anti 65 Amgen Neulasta R 65 vascular disrupting agent 65 factor G CSF 65 advanced hepatocellular carcinoma 65 Fx #A 65 Gliadel Wafer 65 Laquinimod 65 phase IIb 65 ARIKACE 65 HBeAg negative patients 65 gefitinib Iressa 65 IAP inhibitors 65 ularitide 65 EGFR expressing metastatic colorectal 65 mTOR inhibitor 65 cyclophosphamide doxorubicin vincristine 65 Simulect 65 metastatic carcinoid 65 Rebif ® 65 INT# [002] 65 PI3K/Akt pathway inhibitor 65 recurrent GBM 65 Behcet uveitis 65 ALGRX 65 PRTX 65 unresectable locally advanced 65 Fibrin Pad 65 Bevacizumab 65 biologic therapy 65 temsirolimus 65 ABILIFY R 65 infusional 5-FU/LV 65 zanolimumab 65 IL# PE#QQR 65 essential thrombocythemia ET 65 CAELYX 65 Peginterferon alfa 2b 65 developing Bicifadine serotonin 65 Leukine ® 65 leukemia ALL 65 IV metastatic melanoma 65 alkylating agent 65 cell carcinoma RCC 65 TG# [003] 65 ® lenalidomide 65 chemotherapy induced neutropenia 65 refractory indolent non 65 neratinib 65 OMNARIS HFA 65 liposomal doxorubicin 65 HGS ETR1 mapatumumab 65 miconazole Lauriad ® 65 interferon alfa 2a 65 pralatrexate 65 Taxotere docetaxel 65 INCB# [003] 65 post herpetic neuralgia PHN 65 SNT-MC#/idebenone 65 Phase 2b study 65 relapsed ovarian cancer 65 metastatic colorectal carcinoma 65 treatment naïve genotype 65 boosted protease inhibitor 65 #I TM# 65 Randomized Phase 65 ADP receptor antagonist 65 ospemifene 65 Gleevec Glivec 65 velafermin 65 uremic pruritus 65 null responder 65 calcineurin inhibitor 65 non metastatic osteosarcoma 65 metastatic malignant 65 mertansine 65 Talabostat 65 chronic ITP patients 65 relapsed refractory AML 65 stage IIIb IV 65 VEGFR2 inhibitor 65 multicenter Phase II 65 R rilonacept Injection 65 ponatinib 65 Erlotinib 65 Alkeran 65 antiangiogenic therapy 65 proteasome inhibitor 65 R#/MEM # 65 neurogenic orthostatic hypotension 65 Phase Ib IIa 65 Eltrombopag 65 Cannabinor 65 Tesetaxel 65 uric acid lowering 65 Xcellerated T Cells 65 CHOP chemotherapy 65 Darusentan 65 FOLFOX6 chemotherapy regimen 65 Aptivus ® 65 Safinamide 65 CALGB # [002] 65 interferon ribavirin 65 Telavancin 65 indolent follicular non 65 LANTUS ® 65 Amgen Neulasta ® 65 low dose cytarabine 65 nitazoxanide 65 myelofibrosis 65 metastatic colorectal 65 PEG SN# 65 placebo dexamethasone 65 R lenalidomide 65 aflibercept 65 Nitazoxanide 65 BENICAR 65 antimetabolite 65 NATRECOR R 65 Triapine 65 Bendamustine 65 phase III ACCLAIM 65 methylnaltrexone 65 metastatic HRPC 65 pioglitazone HCl 65 registrational trial 65 ofatumumab 65 angiotensin II receptor blocker 65 Tekamlo 65 tyrosine kinase inhibitor TKI 65 Allovectin 7 ® 65 imatinib mesylate 65 generation Hsp# inhibitor 65 Pivotal Phase III 65 stage IIIB 65 Chronic Myeloid Leukemia 65 KRAS mutations occur 65 Tavocept 65 basiliximab 65 EndoTAG TM -1 65 Actemra tocilizumab 65 valsartan amlodipine 65 iniparib 65 pegylated interferon alfa 2a 65 estramustine 65 evaluating picoplatin 65 VAPRISOL 65 Campath alemtuzumab 65 generation purine nucleoside 65 pegylated interferon alfa 65 NATRECOR ® 64 secondary hyperparathyroidism 64 MabCampath 64 calcineurin inhibitors 64 pseudobulbar affect PBA 64 Degarelix 64 Lenalidomide 64 Relapsed Refractory Multiple Myeloma 64 interferon gamma 1b 64 Apaziquone 64 posaconazole 64 EGFR TKI 64 rasagiline tablets 64 Telatinib 64 Arcalyst 64 rNAPc2 64 carcinoma mCRC 64 orally administered inhibitor 64 5 fluorouracil leucovorin 64 Lixivaptan 64 systemic antifungal 64 davunetide intranasal AL 64 doripenem 64 novel topoisomerase 64 rituximab Rituxan 64 FASLODEX 64 IV NSCLC 64 corticosteroid dexamethasone 64 oral antidiabetic medication 64 peginterferon alfa 2a Pegasys 64 oblimersen 64 CANCIDAS 64 unresectable stage 64 relapsed refractory 64 Vidaza azacitidine 64 selective androgen receptor modulator 64 ONTAK 64 TAXOTERE R 64 potent CYP#A# inhibitors 64 irinotecan chemotherapy 64 INC# 64 refractory CTCL 64 mycophenolate mofetil 64 valopicitabine 64 investigational oral hepatitis C 64 Metastatic Melanoma 64 gastrointestinal stromal tumor GIST 64 abiraterone acetate 64 lintuzumab 64 SCH # 64 Phase Ib clinical trials 64 TO AVOID PREGNANCY WHILE 64 vapreotide acetate 64 refractory acute myeloid 64 sunitinib Sutent 64 imetelstat 64 Elvitegravir 64 previously untreated follicular 64 mg/m2 dose 64 MKC# MT 64 intranasal formulation 64 Torisel 64 BENLYSTA TM 64 transcriptase inhibitor NNRTI 64 CYC# 64 familial amyloidotic polyneuropathy FAP 64 systemic fungal infections 64 Diffuse Large B 64 Ceflatonin ® 64 DermaVir Patch 64 INSPIRE Trial Phase III 64 TNF Tumor Necrosis Factor 64 tumor lysis syndrome 64 Alemtuzumab 64 including eniluracil ADH 64 alpha folate receptor 64 PSN# [001] 64 intravenous belinostat 64 metformin sulfonylurea 64 Azacitidine 64 ara C 64 gastrointestinal stromal tumors 64 Vivaglobin 64 unresectable malignant mesothelioma UMM 64 kidney urologic 64 IMGN# 64 alpha 2b 64 Vidaza R 64 Valsartan 64 neovascular diseases 64 evaluating Xcytrin 64 symptomatic BPH 64 TBC# 64 albinterferon alfa 2b 64 leukemia APL 64 etanercept Enbrel 64 humanized interleukin 6 64 delafloxacin 64 pediatric acute lymphoblastic 64 allogeneic HSCT 64 L BLP# 64 Elagolix 64 CD4 monoclonal antibody 64 Paraplatin ® 64 dependent kinase inhibitor 64 Aclidinium 64 Phase 2a clinical 64 Oxaliplatin 64 Lantus ® 64 Surgical resection 64 Vicriviroc 64 MEK Inhibitor 64 MP4OX 64 lapatinib Tykerb 64 Renal Cell Carcinoma RCC 64 COPEGUS ribavirin 64 seliciclib CYC# 64 Mepact 64 oral allopurinol 64 refractory APL 64 Aviptadil 64 dexamethasone Decadron 64 ACZ# 64 Xcytrin R 64 OMP #M# 64 Pirfenidone 64 cariprazine 64 SUTENT ® 64 daily Infergen 64 FOLFIRI chemotherapy 64 treatment naive genotype 64 dexanabinol 64 Onalta 64 metastatic castrate resistant 64 Zevalin R Ibritumomab 64 Albuferon TM 64 PEG INTRON 64 personalized cellular immunotherapy 64 oral talactoferrin 64 EFAPROXYN 64 polymerase inhibitor 64 diagnosed multiple myeloma 64 TEMODAL 64 Sudhir Agrawal D.Phil 64 KNS # 64 FOLFOX chemotherapy 64 nilotinib Tasigna ® 64 selective modulator 64 PROCRIT 64 Decitabine 64 fistulizing Crohn disease 64 dexpramipexole 64 Atiprimod 64 ocrelizumab 64 crizotinib PF # 64 R Bortezomib 64 IRESSA 64 Inhalation Solution 64 LCP Tacro 64 Sym# 64 interferon alfacon 1 64 sodium thiosulfate STS 64 ribavirin Copegus 64 Civacir 64 Onrigin 64 ongoing Phase 1b 64 chemotherapeutic regimen 64 Hepatocellular Carcinoma HCC 64 Cetrorelix 64 active comparator 64 unresectable tumors 64 RAPTIVA 64 Alinia 64 Phase III Pivotal 64 Lubiprostone 64 placebo controlled Phase III 64 Eraxis 64 naïve HCV 64 Dasatinib 64 Prograf ® 64 AeroLEF TM 64 Epoetin alfa 64 evaluating REVLIMID 64 taxane chemotherapy 64 sapacitabine CYC# 64 lenalidomide dexamethasone 64 modified glutathione analog 64 HCD# [002] 64 Viprinex 64 Saizen R 64 veltuzumab 64 peginterferon alfa 2b 64 Raptiva r 64 CLORETAZINE TM VNP#M 64 goserelin 64 ALN TTR# 64 Hycamtin ® 64 acute promyelocytic leukemia APL 64 SCCHN 64 imipenem 64 Luteinizing Hormone Releasing Hormone 64 Gleevec imatinib mesylate 64 interferon alfa 64 clodronate 64 rheumatoid arthritis psoriatic arthritis 64 dose cohort 64 TYKERB 64 recurrent genital herpes 64 Methylnaltrexone 64 talabostat 64 HCV protease inhibitor 64 HuLuc# 64 splenectomized 64 oral anticoagulant 64 cancer mCRC 64 aerosolized AAT 64 clofarabine 64 salmeterol fluticasone 64 hematological malignancies 64 tesmilifene 64 pancreatic adenocarcinoma 64 refractory ovarian cancer 64 sargramostim 64 Cariprazine 64 multicenter Phase 64 prostate cancer CRPC 64 tenofovir emtricitabine 64 Perforomist ™ Inhalation Solution 64 TRISENOX 64 chemotherapy cisplatin 64 Amplimexon 64 AKT inhibitor 64 LymphoStat B 64 Tezampanel 64 ALN PCS 64 dextromethorphan quinidine 64 Kepivance 64 RGB # 64 Perifosine 64 ATACAND 64 Phase 1b clinical 64 Plicera 64 Vandetanib 64 ISENTRESS 64 OXi# 64 Zerenex 64 adenosine injection 64 anti EGFR antibody 64 Phase IIb clinical trials 64 SCIg 64 XL# XL# 64 brentuximab vedotin SGN 64 Randomized Phase II 64 nilotinib Tasigna 63 CTAP# 63 FROVA 63 LHRH antagonists 63 FluCAM 63 trastuzumab Herceptin ® 63 Telintra 63 irinotecan doxorubicin oxaliplatin paclitaxel 63 Peginterferon 63 Pivotal Phase 63 certolizumab 63 Dementia Related Psychosis 63 AAG geldanamycin analog 63 CCR9 antagonist 63 MGCD# [001] 63 Aliskiren 63 recurrent ovarian cancer 63 abatacept Orencia 63 pharmacokinetic PK study 63 fluoropyrimidine 63 CINTREDEKIN BESUDOTOX 63 Initiates Enrollment 63 mixed dyslipidemia 63 Pegasys plus Copegus 63 TLK# 63 TACI Ig 63 Bucindolol 63 angiogenesis inhibitor 63 dirucotide MBP# 63 Wafer polifeprosan 63 randomized controlled Phase 63 Proquin XR 63 BRAF inhibitor 63 REVLIMID lenalidomide 63 alvimopan 63 refractory metastatic 63 AP# [003] 63 Triapine R 63 Phase 2a trial 63 Ecallantide 63 blinatumomab 63 EDEMA3 63 REYATAZ R 63 Campath ® 63 drug ISA# 63 dose escalation phase 63 Metastatic Colorectal Cancer 63 antithrombotic 63 Phase IIb clinical 63 MNTX 63 HBeAg negative 63 Pulmonary Arterial Hypertension 63 PANVAC VF 63 doxorubicin HCl liposome injection 63 vandetanib 63 Symadex 63 long acting muscarinic 63 Carfilzomib 63 metformin HCl 63 Frova ® 63 Tyrima 63 ON #.Na 63 FOLFIRI 63 5-FU/LV 63 Zolinza 63 stage IIIb 63 Pfizer Sutent 63 complement inhibitor eculizumab 63 cinacalcet 63 ribavirin therapy 63 AA amyloidosis 63 BUPHENYL R sodium phenylbutyrate 63 primary immunodeficiency PI 63 Zingo TM 63 sevelamer carbonate 63 myelofibrosis polycythemia vera 63 Folotyn 63 BENICAR HCT 63 sodium glucose cotransporter 63 bevacizumab Avastin

Back to home page